Recombinant Proteins iso9001 ISO13485
搜索
 > 【CEACAM-6】重组蛋白信息

CEACAM-6信息

英文名称:Carcinoembryonic antigen related cell adhesion molecule 6
中文名称:癌胚抗原相关细胞粘附分子6
靶点别称:CEACAM6,CEA Cell Adhesion Molecule 6,CD66c,NCA,Carcinoembryonic Antigen Related Cell Adhesion Molecule 6,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (Non-Specific Cross Reacting Antigen),Normal Cross-Reacting Antigen,Carcinoembryonic Antigen
上市药物数量:0
临床药物数量:2
最高研发阶段:临床二期

CEACAM-6产品列表

货号 物种 产品描述 蛋白结构 纯度 活性
CE6-H5223
Human
Human CEACAM-6 / CD66c Protein, His Tag
CE6-H82E7
Human
Biotinylated Human CEACAM-6 / CD66c Protein, His,Avitag
 
评论(0)
 

CEACAM-6 分子别名

CEACAM6,CD66c,CEAL,NCA

CEACAM-6 分子背景

Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6) is also known as CD66c (Cluster of Differentiation 66c), CEAL, NCA, and is one of seven human CEACAM family members within the immunoglobulin superfamily. In humans, CEACAMs include type I transmembrane proteins (CEACAM1, CEACAM3, and CEACAM4) and GPI-linked molecules (CEACAM5 through CEACAM8). There is no human CEACAM2. CEACAM 6 contains one N-terminal V-type Ig-like domain (N domain), followed by two C2-type Ig-like domains. It shows considerable glycosylation, including (sialyl) LewisX, which mediates binding to E-selectin, galectins and some bacterial fimbrae. CEACAM-6 is expressed by granulocytes and their progenitors. It is also expressed by epithelia of various organs and is upregulated in pancreatic and colon adenocarcinomas, as well as hyperplastic polyps. Resistance to adhesion-related apoptosis in tumor cells is conferred in the condition of CEACAM6 overexpression.

CEACAM-6 参考文献

CEACAM-6临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
NEO-201 NEO-201 临床一期 Precision Biologics, 美国国立癌症研究所 肺腺癌, 胰腺癌, 乳腺癌, 结直肠癌, 鳞状细胞癌 详情
L-DOS-47 L-DOS-47 临床二期 Helix Biopharma 胰腺癌, 肺腺癌, 非小细胞肺癌 详情

消息提示

请输入您的联系方式,再点击提交!

确定